Hospital Notre-Dame du Chum

Montreal, Quebec H2L4M1

0 studies enrolling now · 6 studies all time

What they study most

Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment, Cerebrovascular Accident, Idiopathic Pulmonary Fibrosis, Metastatic Androgen Independent Prostate Cancer, Myelodysplastic Syndromes, Prostate Cancer

Studies at this site

• A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer — Stopped early
• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) — Completed
• Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study — Completed
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS) — Completed
• A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke — Stopped early
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed